However, efficacy, safety, optimal doses and treatment targets have not been established in treatment of predialytic renal failure patients.
Predialüütilise neerupuudulikkusega patsientide ravi efektiivsus, ohutus, optimaalsed annused ja ravieesmärgid on siiski kindlaks tegemata.